Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription Articles published in Compr Psychiatry Retrieve available abstracts of 19 articles: HTML format

Single Articles

October 2025
1. HE Y, Ng SM, Ran MS, Wang C, et al
   Beyond criticism, hostility, and emotional overinvolvement: Development and psychometric validation of the Comprehensive Expressed Emotion Scale (CEES) in schizophrenia.
   Compr Psychiatry. 2025;143:152638.
   PubMed     Abstract available
   
   
   September 2025
2. HAO J, Bruggeman R, Veling W, Alizadeh BZ, et al
   The power of youth: Long-term differential effects of developmental functioning trajectory on social functioning, quality of life and personal recovery across the schizophrenia spectrum.
   Compr Psychiatry. 2025;143:152637.
   PubMed     Abstract available
   
   
   August 2025
3. SHEN H, He Y, Zeng R, Ge L, et al
   Aberrant anterior insula underlies interoceptive deficits in alexithymia among schizophrenia patients.
   Compr Psychiatry. 2025;143:152630.
   PubMed     Abstract available
   
   
   
4. DAVID FS, Frank J, Stein F, Meinert S, et al
   Blood-based DNA methylation profiles in major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
   Compr Psychiatry. 2025;143:152629.
   PubMed     Abstract available
   
   
   July 2025
5. FRILEUX S, Faivre N, Urbach M, Vidal N, et al
   Flowers for Algernon: How metacognition affects quality of life in schizophrenia. Structural equation modeling with the FACE-SZ cohort.
   Compr Psychiatry. 2025;142:152622.
   PubMed     Abstract available
   
   
   
6. CHIAPPINI S, Mosca A, Semeraro F, Amerio A, et al
   Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia.
   Compr Psychiatry. 2025;142:152616.
   PubMed     Abstract available
   
   
   April 2025
7. HAZAK A, Liuhanen J, Kantojarvi K, Sulkava S, et al
   Schizophrenia genetic risk and labour market outcomes in the Finnish general population: Are schizophrenia-related traits penalised or rewarded?
   Compr Psychiatry. 2025;140:152600.
   PubMed     Abstract available
   
   
   February 2025
8. ALEKSANDROWICZ A, Kowalski J, Moritz S, Stefaniak I, et al
   A cognitive model of perceptual anomalies: The role of source monitoring, top-down influence and inhibitory processes for hallucinations in schizophrenia spectrum disorders and hallucinatory-like experiences in the general population.
   Compr Psychiatry. 2025;138:152583.
   PubMed     Abstract available
   
   
   October 2024
9. CASTELEIN S, Visser E, Brilman MF, Wardenaar KJ, et al
   Identifying factors strongest associated with clinical, societal and personal recovery in people with psychosis with a long duration of illness.
   Compr Psychiatry. 2024;136:152540.
   PubMed     Abstract available
   
   
   July 2024
10. SHI X, Sun X, Zhang C, Li Z, et al
    Individual stigma in people with severe mental illness: Associations with public stigma, psychological capital, cognitive appraisal and coping orientations.
    Compr Psychiatry. 2024;132:152474.
    PubMed     Abstract available
    
    
    May 2024
11. REDLICH BOSSY M, Muller DR, Niedermoser DW, Burrer A, et al
    Impact of psychopathology on day-to-day living in patients with schizophrenia: A network analysis.
    Compr Psychiatry. 2024;133:152501.
    PubMed     Abstract available
    
    
    
12. DE FILIPPIS R, Aloi M, Liuzza MT, Pugliese V, et al
    Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia.
    Compr Psychiatry. 2024;133:152496.
    PubMed     Abstract available
    
    
    March 2024
13. SAELE RH, Ndetei DM, Mutiso VN, Mamah D, et al
    Epidemiology of DSM-5 psychiatric disorders in Kenyan Youth with Low and High Psychosis Risk.
    Compr Psychiatry. 2024;131:152473.
    PubMed     Abstract available
    
    
    February 2024
14. ANDREO-JOVER J, Wootton O, Fernandez-Jimenez E, Munoz-Sanjose A, et al
    Adverse childhood experiences and cognition: A cross-sectional study in Xhosa people living with schizophrenia and matched medical controls.
    Compr Psychiatry. 2024;130:152459.
    PubMed     Abstract available
    
    
    January 2024
15. ANDREA S, Jan K, Antonin S, Lea J, et al
    Time is the enemy: Negative symptoms are related to even slight differences in the duration of untreated psychosis.
    Compr Psychiatry. 2024;130:152450.
    PubMed     Abstract available
    
    
    December 2023
16. FELSENHEIMER A, Rapp AM
    Proverb comprehension in schizophrenia: A comprehensive review and meta-analysis.
    Compr Psychiatry. 2023;129:152444.
    PubMed     Abstract available
    
    
    November 2023
17. WOLPE N, Vituri A, Jones PB, Shahar M, et al
    The longitudinal structure of negative symptoms in treatment resistant schizophrenia.
    Compr Psychiatry. 2023;128:152440.
    PubMed     Abstract available
    
    
    September 2023
18. SAMI M, Liddle P
    Neurobiology of psychosis and schizophrenia 2022: Nottingham meeting.
    Compr Psychiatry. 2023;127:152415.
    PubMed    
    
    
    
19. DIDIER PR, Moore TM, Calkins ME, Prettyman G, et al
    Evaluation of a new intrinsic and extrinsic motivation scale in youth with psychosis spectrum symptoms.
    Compr Psychiatry. 2023;127:152413.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.